These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 12644474

  • 1. Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter.
    Cheema SK, Mishra SK, Rangnekar VM, Tari AM, Kumar R, Lopez-Berestein G.
    J Biol Chem; 2003 May 30; 278(22):19995-20005. PubMed ID: 12644474
    [Abstract] [Full Text] [Related]

  • 2. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
    Fraizer G, Leahy R, Priyadarshini S, Graham K, Delacerda J, Diaz M.
    Int J Oncol; 2004 Mar 30; 24(3):461-71. PubMed ID: 14767530
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Par-4, a pro-apoptotic gene, inhibits radiation-induced NF kappa B activity and Bcl-2 expression leading to induction of radiosensitivity in human prostate cancer cells PC-3.
    Chendil D, Das A, Dey S, Mohiuddin M, Ahmed MM.
    Cancer Biol Ther; 2002 Mar 30; 1(2):152-60. PubMed ID: 12170775
    [Abstract] [Full Text] [Related]

  • 6. A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1.
    Johnstone RW, See RH, Sells SF, Wang J, Muthukkumar S, Englert C, Haber DA, Licht JD, Sugrue SP, Roberts T, Rangnekar VM, Shi Y.
    Mol Cell Biol; 1996 Dec 30; 16(12):6945-56. PubMed ID: 8943350
    [Abstract] [Full Text] [Related]

  • 7. Augmented expression of P-gp/multi-drug resistance gene by all-trans retinoic acid in monocytic leukemic cells.
    Tokura Y, Shikami M, Miwa H, Watarai M, Sugamura K, Wakabayashi M, Satoh A, Imamura A, Mihara H, Katoh Y, Kita K, Nitta M.
    Leuk Res; 2002 Jan 30; 26(1):29-36. PubMed ID: 11734301
    [Abstract] [Full Text] [Related]

  • 8. Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4.
    Qiu G, Ahmed M, Sells SF, Mohiuddin M, Weinstein MH, Rangnekar VM.
    Oncogene; 1999 Jan 21; 18(3):623-31. PubMed ID: 9989812
    [Abstract] [Full Text] [Related]

  • 9. The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells.
    Brett A, Pandey S, Fraizer G.
    Mol Cancer; 2013 Jan 08; 12():3. PubMed ID: 23298185
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Wilms' tumor suppressor WT1 enhances CD95L expression and promotes activation-induced cell death in leukemic T cells.
    Bourkoula K, Englert C, Giaisi M, Köhler R, Krammer PH, Li-Weber M.
    Int J Cancer; 2014 Jan 15; 134(2):291-300. PubMed ID: 23832418
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.